ABSTRACT
Escherichia coli heat-labile enterotoxin (LT), which causes a characteristic diarrhea in humans and animals, is a strong mucosal immunogen and has powerful mucosal adjuvant activity towards coadministered unrelated antigens. Here we report the different mucosal adjuvanticity of nontoxic LT derivatives, LTS63Y and LTdelta110/112, generated by immunizing through two different mucosal routes. Intragastric (IG) immunization with Helicobacter pylori urease alone resulted in poor systemic IgG and IgA responses and no detectable local secretory IgA, but IG co-immunization with urease and LTdelta110/112 induced high titers of urease-specific local secretory IgA and systemic IgG and IgA, comparable to those induced by wild-type LT. LTS63Y showed far lower adjuvant activity towards urease than LTdelta110/112 in IG immunization, but was more active than LTdelta110/112 in inducing immune responses to urease by intranasal (IN) immunization. LTdelta110/112 predominantly enhanced the induction of urease-specific IgG1 levels following IG immunization, whereas LTS63Y induced high levels of IgG1, IgG2a and IgG2b following IN immunization. In addition, quantitative H. pylori culture of stomach tissue following challenge with H. pylori demonstrated a 90-95% reduction (p < 0.0002) in bacterial burden in mice immunized intranasally with urease using either mutant LT as an adjuvant. These results indicate that the mechanism(s) underlying the adjuvant activities of mutant LTs towards coadmnistered H. pylori urease may differ between the IN and IG mucosal immunization routes.
Subject(s)
Female , Humans , Mice , Adjuvants, Immunologic/administration & dosage , Administration, Intranasal , Animals , Bacterial Toxins/immunology , Bacterial Toxins/genetics , Bacterial Toxins/administration & dosage , Enterotoxins/immunology , Enterotoxins/genetics , Enterotoxins/administration & dosage , Enzyme-Linked Immunosorbent Assay , Escherichia coli , Feces , Gastric Mucosa/microbiology , Gastric Mucosa/immunology , Helicobacter pylori , Immunoglobulin A, Secretory/immunology , Immunoglobulin G/immunology , Mice, Inbred BALB C , Mutagenesis, Site-Directed , ADP Ribose Transferases/immunology , ADP Ribose Transferases/genetics , Nasal Mucosa/immunology , Point Mutation , Urease/immunology , Urease/administration & dosage , VaccinationABSTRACT
Escherichia coli heat-labile enterotoxin (LT) is composed of catalytic A and non-catalytic homo-pentameric B subunits and causes diarrheal disease in human and animals. In order to produce a nontoxic LT for vaccine and adjuvant development, two novel derivatives of LT were constructed by a site-directed mutagenesis of A subunit; Ser63 to Tyr63 in LTS63Y and Glu110, Glu112 were deleted in LT delta 110/112. The purified mutant LTs (mLTs) showed a similar molecular structural complex as AB5 to that of wild LT. In contrast to wild-type LT, mLTs failed to induce either elongation activity, ADP-ribosyltransferase activity, cAMP synthesis in CHO cells or fluid accumulation in mouse small intestine in vivo. Mice immunized with mLTs either intragastrically or intranasally elicited high titers of LT-specific serum and mucosal antibodies comparable to those induced by wild-type LT. These results indicate that substitution of Ser63 to Tyr63 or deletion of Glu110 and Glu112 eliminate the toxicity of LT without a change of AB5 conformation, and both mutants are immunogenic to LT itself. Therefore, both mLTs may be used to develop novel anti-diarrheal vaccines against enterotoxigenic E. coli.
Subject(s)
Female , Mice , Amino Acid Substitution , Animals , Bacterial Toxins/toxicity , Bacterial Toxins/metabolism , Bacterial Toxins/immunology , Bacterial Toxins/genetics , CHO Cells , Cyclic AMP/metabolism , Enterotoxins/toxicity , Enterotoxins/metabolism , Enterotoxins/immunology , Enterotoxins/genetics , Enzyme-Linked Immunosorbent Assay , Escherichia coli/metabolism , Escherichia coli/genetics , Cricetinae , Immunoglobulin A, Secretory/blood , Ileum/metabolism , Immunity, Mucosal , Mice, Inbred BALB C , Mutagenesis, Site-Directed , ADP Ribose Transferases/metabolism , Recombinant Proteins/toxicity , Recombinant Proteins/metabolism , Recombinant Proteins/immunology , Recombinant Proteins/chemistryABSTRACT
No abstract available.